Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG-DENMARK-COVID trial in health care workers
2020-001888-90Phase 3Completed
- Sponsor
- University of Southern Denmark
- Start
- Apr 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of bcg vaccine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by University of Southern Denmark. Primary endpoint: Number of days of unplanned absenteeism for any reason. Started Apr 2020; status: completed.
02
Drugs
bcg vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001888-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001888-90.